920 Aspen Court, Boston 

Clinic Hours:

9:00am – 5:00pm (Mon-Fri) 

Clinic Number




Dr. Karim Tabiti has joined Requalite GmbH

We are excited to share thatDr. Karim Tabiti has joinedRequalite GmbHteam as Chief Strategy Officer effective from 01st March 2023. Dr Tabiti graduated from Technical University of Munich and then Obtained his PhD in molecular biology from the Institute of Molecular Pathology-Vienna University and continued his research career as a Postdoc at Institute of Molecular and Cell Biology (IMCB) in Singapore. Dr Tabiti has then accumulated more than 25 years of experience in Medical device industry companies including Roche, Immune Diagnostic Systems, and in a joint venture of Qiagen. Dr Tabiti then took theresponsibility of managing the Biotype Diagnostics GmbH (later Biotype GmbH) as chief executive officer. Dr Tabiti has been acting in the advisory board of several biotech companies since 2013. 
Dr Tabiti will be joiningRequalite GmbH’s leading team and will resume Business development activities, general Advisory, and Overall Company’s Strategic Planning. We are thrilled to have Dr Karim Tabiti with us and wish him all the success ! 

Featured Articles

Featured video

Requalite: Regulatory and Clinical Study Services for Medical Device Compliance

Healthy Newsletter

Quo ea etiam viris soluta, cum in aliquid oportere. Eam id omnes alterum. Mei velit